Literature DB >> 27449553

Heart rate variability and generalized anxiety disorder during laboratory-induced worry and aversive imagery.

Jason C Levine1, Raymond Fleming2, Joanna I Piedmont3, Samantha M Cain3, Wei-Ju Chen2.   

Abstract

BACKGROUND: To date only a few published studies have examined the effect of disorder-relevant stressors on heart rate variability (HRV) in participants meeting a clinical diagnosis of GAD, with conflicting results. The primary aim of this study was to determine if GAD is associated with lower HRV at rest, and whether vagal regulation during task varies by type (i.e., baseline, anticipation, imagery, or worry).
METHODS: This study investigated resting cardiac vagal tone and vagal regulation in a sample of 40 participants with or without a validated diagnosis of generalized anxiety disorder (GAD). High-frequency heart rate variability (HF-HRV) was used to index cardiac vagal activity.
RESULTS: GAD was associated with vagal withdrawal during both imagery and worry inductions, but no group differences in resting vagal tone or worry were observed. LIMITATIONS: Methodological limitations include inherent limits to generalizability of laboratory-based findings; specifically worry induction and cardiac reactivity to lab-based stressors.
CONCLUSIONS: The results support the notion that GAD is associated with vagal withdrawal during active bouts of idiographic worry and imagery, and question the assumption that GAD is associated with low resting vagal tone. In light of polyvagal theory these findings provide additional support for the presence of emotion regulation deficits in GAD, and identify specific ANS processes that underlie GAD.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Generalized anxiety disorder; Heart rate; Parasympathetic nervous system; Worry

Mesh:

Year:  2016        PMID: 27449553     DOI: 10.1016/j.jad.2016.07.019

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  7 in total

Review 1.  Psychophysiological Markers of Fear and Anxiety.

Authors:  Jamiah Hyde; Katherine M Ryan; Allison M Waters
Journal:  Curr Psychiatry Rep       Date:  2019-06-04       Impact factor: 5.285

2.  Infant Social Withdrawal Behavior: A Key for Adaptation in the Face of Relational Adversity.

Authors:  Sylvie Viaux-Savelon; Antoine Guedeney; Alexandra Deprez
Journal:  Front Psychol       Date:  2022-06-20

3.  Glutamate Within the Marmoset Anterior Hippocampus Interacts with Area 25 to Regulate the Behavioral and Cardiovascular Correlates of High-Trait Anxiety.

Authors:  Jorge L Zeredo; Shaun K L Quah; Chloe U Wallis; Laith Alexander; Gemma J Cockcroft; Andrea M Santangelo; Jing Xia; Yoshiro Shiba; Jeffrey W Dalley; Rudolf N Cardinal; Angela C Roberts; Hannah F Clarke
Journal:  J Neurosci       Date:  2019-02-04       Impact factor: 6.167

4.  Heart rate variability change during a stressful cognitive task in individuals with anxiety and control participants.

Authors:  Judith Held; Andreea Vîslă; Christine Wolfer; Nadine Messerli-Bürgy; Christoph Flückiger
Journal:  BMC Psychol       Date:  2021-03-17

5.  Anxiety reduction through art therapy in women. Exploring stress regulation and executive functioning as underlying neurocognitive mechanisms.

Authors:  Annemarie Abbing; Leo de Sonneville; Erik Baars; Daniëlle Bourne; Hanna Swaab
Journal:  PLoS One       Date:  2019-12-03       Impact factor: 3.240

6.  Adversity History Predicts Self-Reported Autonomic Reactivity and Mental Health in US Residents During the COVID-19 Pandemic.

Authors:  Jacek Kolacz; Lourdes P Dale; Evan J Nix; Olivia K Roath; Gregory F Lewis; Stephen W Porges
Journal:  Front Psychiatry       Date:  2020-10-27       Impact factor: 4.157

7.  Cardiac Startle Response and Clinical Outcomes in Preschool Children With Fragile X Syndrome and Autism Spectrum Disorder.

Authors:  Jordan Ezell; Abigail Hogan; Elizabeth A Will; Kayla Smith; Jane Roberts
Journal:  Front Psychiatry       Date:  2022-01-03       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.